About mimedx group inc. - MDXG
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
MDXG At a Glance
MiMedx Group, Inc.
1775 West Oak Commons Court NE
Marietta, Georgia 30062
| Phone | 1-770-651-9100 | Revenue | 418.63M | |
| Industry | Medical Specialties | Net Income | 48.58M | |
| Sector | Health Technology | 2025 Sales Growth | 19.993% | |
| Fiscal Year-end | 12 / 2026 | Employees | 808 | |
| View SEC Filings |
MDXG Valuation
| P/E Current | 12.084 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 20.869 |
| Price to Sales Ratio | 2.421 |
| Price to Book Ratio | 3.908 |
| Price to Cash Flow Ratio | 13.70 |
| Enterprise Value to EBITDA | 11.046 |
| Enterprise Value to Sales | 2.078 |
| Total Debt to Enterprise Value | 0.026 |
MDXG Efficiency
| Revenue/Employee | 518,106.436 |
| Income Per Employee | 60,121.287 |
| Receivables Turnover | 5.53 |
| Total Asset Turnover | 1.38 |
MDXG Liquidity
| Current Ratio | 4.318 |
| Quick Ratio | 3.923 |
| Cash Ratio | 2.585 |
MDXG Profitability
| Gross Margin | 82.223 |
| Operating Margin | 15.261 |
| Pretax Margin | 15.828 |
| Net Margin | 11.604 |
| Return on Assets | 16.017 |
| Return on Equity | 21.607 |
| Return on Total Capital | 17.406 |
| Return on Invested Capital | 19.751 |
MDXG Capital Structure
| Total Debt to Total Equity | 8.783 |
| Total Debt to Total Capital | 8.074 |
| Total Debt to Total Assets | 6.576 |
| Long-Term Debt to Equity | 7.684 |
| Long-Term Debt to Total Capital | 7.063 |